A detailed history of Bray Capital Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Bray Capital Advisors holds 26,463 shares of JNJ stock, worth $3.95 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
26,463
Previous 26,555 0.35%
Holding current value
$3.95 Million
Previous $4.16 Million 0.58%
% of portfolio
1.1%
Previous 1.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$155.22 - $162.74 $14,280 - $14,972
-92 Reduced 0.35%
26,463 $4.19 Million
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $291 - $317
2 Added 0.01%
26,555 $4.16 Million
Q3 2023

Oct 27, 2023

BUY
$155.75 - $174.48 $14,329 - $16,052
92 Added 0.35%
26,553 $4.14 Million
Q2 2023

Jul 28, 2023

SELL
$154.35 - $166.11 $23,769 - $25,580
-154 Reduced 0.58%
26,461 $4.38 Million
Q1 2023

Apr 28, 2023

SELL
$151.05 - $180.26 $2,869 - $3,424
-19 Reduced 0.07%
26,615 $4.13 Million
Q4 2022

Jan 20, 2023

SELL
$160.2 - $179.79 $244,144 - $273,999
-1,524 Reduced 5.41%
26,634 $0
Q3 2022

Nov 21, 2022

SELL
$161.33 - $179.52 $10,486 - $11,668
-65 Reduced 0.23%
28,158 $4.6 Million
Q2 2022

Aug 01, 2022

SELL
$168.19 - $186.01 $12,277 - $13,578
-73 Reduced 0.26%
28,223 $5.01 Million
Q1 2022

May 03, 2022

BUY
$158.14 - $179.59 $19,925 - $22,628
126 Added 0.45%
28,296 $5.02 Million
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $244,186 - $270,933
1,566 Added 5.89%
28,170 $4.82 Million
Q3 2021

Oct 28, 2021

BUY
$161.5 - $179.47 $29,393 - $32,663
182 Added 0.69%
26,604 $4.3 Million
Q2 2021

Jul 28, 2021

BUY
$159.48 - $171.07 $84,683 - $90,838
531 Added 2.05%
26,422 $4.35 Million
Q1 2021

May 03, 2021

BUY
$153.07 - $170.48 $114,802 - $127,859
750 Added 2.98%
25,891 $4.26 Million
Q4 2020

Jan 28, 2021

BUY
$137.11 - $157.38 $57,311 - $65,784
418 Added 1.69%
25,141 $3.96 Million
Q3 2020

Oct 30, 2020

BUY
$140.38 - $153.83 $23,724 - $25,997
169 Added 0.69%
24,723 $3.68 Million
Q2 2020

Jul 28, 2020

BUY
$128.81 - $155.51 $66,723 - $80,554
518 Added 2.16%
24,554 $3.45 Million
Q1 2020

May 01, 2020

SELL
$111.14 - $153.99 $24,006 - $33,261
-216 Reduced 0.89%
24,036 $3.15 Million
Q4 2019

Jan 31, 2020

SELL
$127.5 - $146.44 $103,912 - $119,348
-815 Reduced 3.25%
24,252 $3.54 Million
Q3 2019

Oct 29, 2019

SELL
$126.95 - $142.14 $89,372 - $100,066
-704 Reduced 2.73%
25,067 $3.24 Million
Q2 2019

Jul 29, 2019

BUY
$131.15 - $144.24 $116,854 - $128,517
891 Added 3.58%
25,771 $3.59 Million
Q1 2019

Apr 30, 2019

BUY
$125.72 - $139.79 $39,350 - $43,754
313 Added 1.27%
24,880 $3.48 Million
Q4 2018

Feb 15, 2019

BUY
$122.84 - $147.84 $56,137 - $67,562
457 Added 1.9%
24,567 $3.17 Million
Q3 2018

Oct 31, 2018

SELL
$121.58 - $142.88 $6,808 - $8,001
-56 Reduced 0.23%
24,110 $3.33 Million
Q2 2018

Jul 31, 2018

SELL
$119.4 - $131.76 $4,417 - $4,875
-37 Reduced 0.15%
24,166 $2.93 Million
Q1 2018

May 04, 2018

SELL
$125.1 - $148.14 $91,948 - $108,882
-735 Reduced 2.95%
24,203 $3.1 Million
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $34,117 - $37,341
-260 Reduced 1.03%
24,938 $3.48 Million
Q3 2017

Nov 01, 2017

BUY
$129.47 - $135.38 $3.26 Million - $3.41 Million
25,198
25,198 $3.28 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $391B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bray Capital Advisors Portfolio

Follow Bray Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bray Capital Advisors with notifications on news.